TGNA.F 1 (-4.76%)
FR0005175080BiotechnologyBiotechnology

Transgene (TGNA.F) Stock Highlights

1 | -4.76%
2024-06-19 04:31:54
Transgene SA is a biotechnology company. It is involved in the business of discovering and focusing immune-targeted therapies for the treatment of cancer and infectious diseases. The companys lead clinical-stage programs are TG4010 for non-small cell lung cancer and Pexa-vec for liver cancer. Its product pipeline includes TG4001, TG1050, TG6002 etc. The firm is based in Strasbourg, France has additional operations in Lyon as well as satellite offices in China and United States. Its subsidiary represents the company before various bodies, regulatory authorities and clinical sites for clinical trials it conducts in the US.

Statistics

Range Today
1 1
Volume Today 0
Range 1 Year
1.01 1.95
Volume 1 Year 20.04K
Range 3 Year
1.01 2.9
Volume 3 Year 107.76K
Range 10 Year
0.841 10.0187
Volume 10 Year 575.88K

Highlights

Market Capitalization 124.96M (small)
Floating Shares 34.53M
Current Price 1
Price To Earnings -5.21
Price To Revenue 14.79
Price To Book 7.39
Earnings Per Share -0.22
Payout Ratio 0%

Performance

Latest -4.76%
1 Month -23.66%
3 Months -9.09%
6 Months -28.06%
1 Year -47.37%
3 Years -61.46%
5 Years -59.92%
10 Years -89.7%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.